# OnCo record destiny-breast09 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/destiny-breast09/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "destiny-breast09", "NCT04784715" ;
  schema:name "DESTINY-Breast09"@en ;
  schema:description "Showed Enhertu plus pertuzumab beats the decade-old first-line standard for HER2-positive metastatic breast cancer."@en ;
  schema:url <https://onco.cc/trials/destiny-breast09/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04784715> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2021-04-26" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:companies <https://onco.cc/companies/daiichi-sankyo/>, <https://onco.cc/companies/astrazeneca/> ;
  onco:people <https://onco.cc/people/cristina-saura/>, <https://onco.cc/people/javier-cortes/>, <https://onco.cc/people/sara-tolaney/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-destiny-breast09-n-engl-j-med-2026/> .